Author response for "Cardiovascular and kidney outcomes of linagliptin treatment in older people with type 2 diabetes and established cardiovascular disease and/or kidney disease: A prespecified subgroup analysis of the randomized, placebo‐controlled CARMELINA® trial"
Keyword(s):
2019 ◽
Keyword(s):
2020 ◽
Keyword(s):
2019 ◽
Keyword(s):
2019 ◽
Keyword(s):
2019 ◽
Keyword(s):
Cardiovascular and kidney outcomes of linagliptin treatment in older people with type 2 diabetes and established cardiovascular disease and/or kidney disease: A prespecified subgroup analysis of the randomized, placebo‐controlled CARMELINA® trial
2020 ◽
Vol 22
(7)
◽
pp. 1062-1073
◽
Keyword(s):
2020 ◽
Keyword(s):
2019 ◽
Keyword(s):
2020 ◽
Keyword(s):
2019 ◽
Keyword(s):
